Explore more publications!

Press Releases

Orion180 Ranked Number 367 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Reliable Heating System Repair and Plumbing Solutions in Stoneham MA
PMA Consultants Reaches 300 Employees: A Milestone in Sustained Growth
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results
Commercial Marine Licensing Event to Be Held on December 19, 2025

Commercial Marine Licensing Event to Be Held on December 19, 2025

Reliable Heat Pump Repair and Plumbing Solutions in Stoneham MA
Commercial Marine Licensing Event to Be Held on December 19, 2025

Commercial Marine Licensing Event to Be Held on December 19, 2025

ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
Vantage MedTech Appoints Carlo W. Colesanti as President and Chief Executive Officer; Jim Bartel to Serve as Chief Commercial Officer; Randy Barko Named Executive Chairman of the Board
Wearable Cardiac Devices Market Size to Surpass USD 32.16 Bn by 2034
China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
HYCU® Recognized as CRN 2025 Products of the Year Finalist
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions